$3.00
0.000400.01%
Pre-Market: 7:34 PM EDT
Comments
Loading...
Amylyx Pharma Earnings Estimates, EPS & Revenue | NASDAQ:AMLX | Benzinga
Amylyx Pharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 8
EPS Estimate
$-0.650
Quarterly Revenue Estimate
–
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$196.49M
Analyze the earnings history of Amylyx Pharma using advanced sorting and filters.
Data brought to you by Benzinga APIs
Amylyx Pharma (AMLX) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-04 | $-0.55 | $-0.59 | 6.78 % |
| Q3 | 2024-11-07 | $-0.53 | $-0.71 | 25.4 % |
| Q2 | 2024-08-08 | $-0.73 | $-0.73 | 0.00 % |
| Q1 | 2024-05-09 | $-0.12 | $-0.01 | -1100.0 % |
Amylyx Pharma (AMLX) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | 2024-08-08 | $-1.20M | $10.66M | -111.3 % |
| Q1 | 2024-05-09 | $88.64M | $98.35M | -9.87 % |
| Q4 | 2024-02-22 | $108.45M | $106.96M | 1.39 % |
| Q3 | 2023-11-09 | $102.69M | $114.26M | -10.1 % |
FAQ
When is Amylyx Pharma (NASDAQ:AMLX) reporting earnings?
Amylyx Pharma (AMLX) is scheduled to report earnings on May 8, 2025. The last reported earnings were for reported on March 4, 2025 for Q4.
What were the latest earnings per share (EPS) for Amylyx Pharma (NASDAQ:AMLX)?
The Actual EPS was $-0.55, which beat the estimate of $-0.59.
What were Amylyx Pharma’s (NASDAQ:AMLX) revenues?
The Actual Revenue was $-665K, which missed the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.